Retraction
Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients
Paper Information
Record ID:
52284
Author(s):
Journal:
Publication Date:
March 12, 2022
Retraction Date:
August 02, 2023
(2.3 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9806931Citations (4)
4
Total Citations0
Post-Retraction3
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Cancer- related protein profile of patient-derived and commercial glioblastoma cell lines exposed to Temozolomide
Anna Maria Bielecka Wajdman, Grzegorz Machnik, Michael Linnebacher et al. (5 authors)
Research Square (Research Square)
Open Access
Published: Apr 2023
114 days before retraction
Retracted: Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients
Journal of Healthcare Engineering
Journal of Healthcare Engineering
Open Access
Published: Jan 2023
1 citation
1 citation
213 days before retraction
Prediction of IDH1 Gene expression in Glioblastoma Using Machine Learning Techniques
Shanjana Shuravi Shawon, Shaila Afrin, Mst. Nilufa Yeasmin et al. (5 authors)
Unknown Journal
Published: Dec 2022
1 citation
1 citation
228 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
2.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025